NCT06425601

Brief Summary

The goal of this prospective randomized clinical trial is to compare the impact of the chest tube type on pain, chest drainage efficacy and early postoperative outcome following VATS lobectomy for lung cancer. The main questions it aims to answer are:

  • silicone chest drains are less painful compared to standard PVC drains?
  • is there any difference in chest drainage efficacy and short term outcome between the two groups? Researchers will compare silicone chest drain group with PVC chest drain group to see if there is any difference in postoperative pain, chest drainage efficacy and short term outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable postoperative-pain

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 8, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 22, 2024

Completed
Last Updated

May 22, 2024

Status Verified

May 1, 2024

Enrollment Period

2.9 years

First QC Date

May 8, 2024

Last Update Submit

May 17, 2024

Conditions

Keywords

VATSlung lobectomypostoperative painchest drainanalgesia

Outcome Measures

Primary Outcomes (5)

  • Analgesics consumption

    Amount of analgesics used first two days after the surgery was analyzed and reported in milligrams. Higher scores mean a worse outcome.

    2 days

  • Need for peroral analgesia after the chest tube removal

    Need for peroral analgesia at first, second and fourth week after chest tube removal was assessed and reported as frequency in number. Higher scores mean a worse outcome.

    2 days

  • Maximal inspiratory pressure

    Post-operative pain during the first two days after the surgery was analyzed by measuring the maximal inspiratory pressure (MIP) in cmH2O. Higher scores mean a better outcome.

    2 days

  • Maximal expiratory pressure

    Post-operative pain during the first two days after the surgery was analyzed by measuring the maximal expiratory pressure (MEP) in cmH2O. Higher scores mean a better outcome.

    2 days

  • Visual analogue scale

    Post-operative pain during the first two days after the surgery was analyzed by using the visual analogue scale (VAS). Scale tittle was Visual Analogue Scale. Minimum value on a scale was 0 and maximum value was 10. Higher scores mean a worse outcome.

    2 days

Secondary Outcomes (11)

  • Duration of chest drainage

    1 month

  • Pneumothorax rate on the day of surgery

    First day

  • Pneumothorax rate after chest tube removal

    1 month

  • Pleural effusion rate on the day of surgery

    First day

  • Pleural effusion rate after chest tube removal

    1 month

  • +6 more secondary outcomes

Study Arms (2)

Silicone (SIL) group

EXPERIMENTAL

For postoperative pleural space drainage a silicone coaxial drain of size French 24 (Redax Coaxial Drain, Redax S.p.A., Poggio Rusco Mantova, Italy) was used

Device: SIL drain

PVC group

ACTIVE COMPARATOR

For postoperative pleural space drainage a standard polyvinyl chloride drain of size French 24 (Argyle, Covidien, Mansfield, USA) was used

Device: PVC drain

Interventions

SIL drainDEVICE

Silicone chest tube used for pleural space drainage after VATS lobectomy

Silicone (SIL) group
PVC drainDEVICE

Polyvinyl chloride chest tube used for pleural space drainage after VATS lobectomy

PVC group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • primary lung cancer eligible for VATS lobectomy by tumor board meeting

You may not qualify if:

  • age under 18 years
  • high risk of post-operative complications (ASA \> 3, diffusion capacity for transfer factor (TLCO) or forced expiratory volume at one second (FEV1) ≤ 40%, cycle ergometry with oxygen consumption (VO2 max) \< 15 ml/kg/min)
  • tumors growing in parietal pleura
  • extended lung resection diffuse
  • previous surgery in the same hemithorax
  • chronic pain
  • chronic use of analgesics or sedatives
  • surgical revision
  • inability to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Centre Ljubljana

Ljubljana, 1000, Slovenia

Location

Related Publications (1)

  • Greif B, Zgajnar J, Stupnik T. Impact of chest tube type on pain, drainage efficacy, and short-term treatment outcome following video-assisted thoracoscopic surgery lobectomy: a randomized controlled trial comparing coaxial silicone drains and standard polyvinyl chloride drains. J Thorac Dis. 2025 Feb 28;17(2):932-943. doi: 10.21037/jtd-24-1489. Epub 2025 Feb 21.

MeSH Terms

Conditions

Pain, PostoperativePostoperative ComplicationsAgnosia

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Officials

  • Boris Greif

    UMC Ljubljana

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Thoracic Surgery

Study Record Dates

First Submitted

May 8, 2024

First Posted

May 22, 2024

Study Start

September 30, 2020

Primary Completion

August 10, 2023

Study Completion

August 10, 2023

Last Updated

May 22, 2024

Record last verified: 2024-05

Locations